Fig. 6From: Adherence to interferon β-1a therapy using an electronic self-injector in multiple sclerosis: a multicentre, single-arm, observational, phase IV studyPatient self-reported degree of “bother” associated with RebiSmart® use (mITT population) Based on patient response to the following question: “How bothersome was the amount of time and preparation it took to get everything ready for your Rebif® injection with RebiSmart®?”Back to article page